Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Sivanandhan · SciRah

Researcher profile · Semantic Scholar

D. Sivanandhan

Share profile

D. Sivanandhan — researcher profile on SciRah

h-index: 7
Works: 27
Citations: 234

Most-cited papers

A novel selective inhibitor JBI-589 targets PAD4-mediated neutrophil migration to suppress tumor progression
Hui Deng, Cindy Lin, Laura Garcia-Gerique, Shuyu Fu +14 more
2022Cancer Research82 citations Open access
Semantic Scholar
Alleviation of arthritis through prevention of neutrophil extracellular traps by an orally available inhibitor of protein arginine deiminase 4
Chandru Gajendran, Shoichi Fukui, N. Sadhu, M. Zainuddin +11 more
2023Scientific Reports62 citations Open access
Semantic Scholar
Novel Dual LSD1/HDAC6 inhibitors for the treatment of Multiple Myeloma.
M. Sadhu, D. Sivanandhan, Chandru Gajendran, S. Tantry +7 more
2020Bioorganic & Medicinal Chemistry Letters31 citations Open access
Semantic Scholar
Novel dual LSD1/HDAC6 inhibitor for the treatment of cancer
Chandru Gajendran, S. Tantry, Naveen Sadhu M, Zainuddin Mohammed +7 more
2023PLoS ONE16 citations Open access
Semantic Scholar
Inhibition of protein arginine deiminase 4 prevents inflammation-mediated heart failure in arthritis
L. Heger, Nicolas Schommer, Shoichi Fukui, S. Van Bruggen +6 more
2023Life Science Alliance15 citations Open access
Semantic Scholar
Discovery and optimization of novel phenyldiazepine and pyridodiazepine based Aurora kinase inhibitors.
Natarajan Tamizharasan, Chandru Gajendran, Rajendra Kristam, S. Sulochana +5 more
2020Bioorganic chemistry (Print)8 citations
Semantic Scholar
Abstract 1756: JBI-802, novel dual inhibitor of LSD1-HDAC6 for treatment of cancer
D. Sivanandhan, S. Rajagopal, S. Nair, Basavaprabhu B +8 more
2020Experimental and Molecular Therapeutics7 citations
Semantic Scholar
Abstract 6269: JBI-778, a novel brain-penetrant small molecule PRMT5 inhibitor for treatment of cancer
D. Sivanandhan, Chandru Gajendran, Naveen Sadhu M, Zainuddin Mohammed +6 more
2023Cancer Research3 citations
Semantic Scholar
Abstract 3509: Novel dual inhibitors of LSD1-HDAC for treatment of cancer
D. Sivanandhan, S. Rajagopalan, S. Nair, Purushottam M. Dewang +15 more
20153 citations
Semantic Scholar
Abstract LB-232: Potent, novel small molecule inhibitors targeting EGFR L858R/T790M mutation for non-small cell lung cancer
D. Sivanandhan, P. Parikh, Avinash Sheshachalam, Chandregowda V +4 more
20142 citations
Semantic Scholar
Abstract 6214: OncodynamiX as an artificial intelligence (AI) based platform for precision medicine
D. Sivanandhan, P. Bhargav, Sumanth M. Vasista, Sirisha Narayanbhatla +4 more
2024Cancer Research1 citations
Semantic Scholar
Abstract B029: LSD1-HDAC6 dual inhibitor JBI-802 is an epigenetic modulating agent with a novel mechanism of action that target MYC amplification in multiple neuroendocrine tumor types
D. Sivanandhan, S. Rajagopal, Chandru Gajendran, N. Sadhu +3 more
2022Cancer Research1 citations
Semantic Scholar
Abstract 2646: Novel, isoform selective PAD4 inhibitors for the treatment of cancer
D. Sivanandhan, S. Rajagopal, Chandru G, Mohd Zainuddin +12 more
2022Cancer Research1 citations
Semantic Scholar
Abstract 5860: Novel, first-in-class dual inhibitors of lysine specific demethylase 1 (LSD1) and histone deacetylatse 1 (HDAC) for treatment of cancer
D. Sivanandhan, S. Nair, Subramaniyam Tantry, S. Rajagopal +16 more
2018Experimental and Molecular Therapeutics1 citations
Semantic Scholar
Abstract B150: ASN007, a novel oral ERK inhibitor, shows robust antitumor activity in RAS mutant cancer models
Sanjeeva P. Reddy, D. Sivanandhan, Purushottam M. Dewang, N. Rao +2 more
20181 citations
Semantic Scholar
Synergistic action of first-in-class anti-tropomyosin compound, ATM-3507 (Anisina) and microtubule targeting inhibitors in pre-clinical models of non-small cell lung cancer (NSCLC)
J. Stehn, A. Mariana, T. Failes, V. Ashokakumar +7 more
20161 citations
Semantic Scholar
Abstract C134: EN3356, a novel CYP17A inhibitor for the treatment of castration resistant prostate cancer.
N. Laping, D. Sivanandhan, R. R. Kethiri, Purushottam M. Dewang +8 more
20131 citations
Semantic Scholar
Abstract 4388: Novel small molecule on state inhibitor for GTP bound pan-KRAS (G12) mutations
Chandru Gajendran, N. Sadhu, R. Gosu, M. Zainuddin +2 more
2025Cancer Research0 citations
Semantic Scholar
1386 Novel gut-restricted small molecule inhibitor of PD-L1 for targeting GI cancers
D. Sivanandhan, S. Rajagopal, Chandru Gajendran, Naveen Sadhu M +3 more
2022Regular and Young Investigator Award Abstracts0 citations Open access
Semantic Scholar
Abstract 1630: Novel, small molecule inhibitors of PD-L1/PD-1 interaction
D. Sivanandhan, S. Rajagopal, Naveen Sadhu M, Chandru Gajendran +13 more
2021Immunology0 citations
Semantic Scholar
Abstract 1128: Selective, novel, small molecule PRMT5 inhibitors for treatment of cancer
D. Sivanandhan, S. Rajagopal, Naveen Sadhu M, Chandru Gajendran +14 more
2021Experimental and Molecular Therapeutics0 citations
Semantic Scholar
Abstract 11: Novel dual inhibitors of LSD1-HDAC6/8 for treatment of cancer
D. Sivanandhan, S. Rajagopal, S. Nair, Chandru Gajendran +16 more
2019Cancer Chemistry0 citations
Semantic Scholar
2134-P: Protection of Beta-Cell Mass from Diabetogenic Condition-Induced Apoptosis by the Inhibition of Mammalian STE20-Like Protein Kinase 1 (MST1)
Zaheer Sameermahmood, D. Sivanandhan, B. Kalita, Sowmya Ramaiah +13 more
2019Diabetes0 citations
Semantic Scholar
Abstract 4856: Novel, small-molecule PRMT5 inhibitors for treatment of cancer
D. Sivanandhan, Shivani Garapaty, S. Vadivelu, G. Seerapu +15 more
2018Experimental and Molecular Therapeutics0 citations
Semantic Scholar
Abstract 5578: Small molecule modulators to understand the role of IDO1 and TDO2 in cancer
Shivani Garapaty, D. Sivanandhan, G. Seerapu, S. Naidu +13 more
20170 citations
Semantic Scholar
Abstract 187: ASN0007, a potent ERK1/2 inhibitor with strong antitumor activity in multiple RAS mutant models
Sanjeeva P. Reddy, D. Sivanandhan, R. R. Kethiri, S. Nair +6 more
20160 citations
Semantic Scholar
Abstract PR09: EZH2 inhibitors reveal broad EZH2 dependencies in multiple myeloma
Shilpi Arora, K. Williamson, S. Balasubramanian, J. Busby +6 more
20160 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Rajagopal×15
Invite
S. Rajagopal — researcher profile on SciRah
Chandru Gajendran×12
Invite
Chandru Gajendran — researcher profile on SciRah
Mohd Zainuddin×10
Invite
Mohd Zainuddin — researcher profile on SciRah
R. Gosu×8
Invite
R. Gosu — researcher profile on SciRah

Purushottam M. Dewang

×8

Invite

Purushottam M. Dewang — researcher profile on SciRah

Invite

S. Nair — researcher profile on SciRah

Invite

R. G — researcher profile on SciRah

S. Rajagopal×6

Invite

S. Rajagopal — researcher profile on SciRah

M. Zainuddin×5

Invite

M. Zainuddin — researcher profile on SciRah

Naveen Sadhu M×5

Invite

Naveen Sadhu M — researcher profile on SciRah

Amir Siddiqui×5

Invite

Amir Siddiqui — researcher profile on SciRah

Invite

N. Sadhu — researcher profile on SciRah